Correlation between serum CEA level and metabolic volume as determined by FDG PET in postoperative patients with recurrent colorectal cancer
To determine the correlation between serum CEA level and the metabolic volume by FDG PET in postoperative patients with recurrent colorectal cancer, FDG PET was performed in 29 consecutive patients with recurrent or metastatic colorectal cancer whose CEA levels were higher than 5 ng/ml. A whole body...
Gespeichert in:
| Veröffentlicht in: | Annals of nuclear medicine 2005-04, Vol.19 (2), p.123-129 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 129 |
|---|---|
| container_issue | 2 |
| container_start_page | 123 |
| container_title | Annals of nuclear medicine |
| container_volume | 19 |
| creator | Choi, Mi Yeon Lee, Kwang Min Chung, June-Key Lee, Dong Soo Jeong, Jae Min Park, Jae Gahb Kim, Jung-Hoe Lee, Myung Chul |
| description | To determine the correlation between serum CEA level and the metabolic volume by FDG PET in postoperative patients with recurrent colorectal cancer, FDG PET was performed in 29 consecutive patients with recurrent or metastatic colorectal cancer whose CEA levels were higher than 5 ng/ml. A whole body emission scan was performed 60 minutes after injecting 370-555 MBq of F-18 FDG. "PET volume" and "PET metabolic volume" of tumors were measured on FDG PET images. Based on an isocontour plot of tumor mass at 2.5 SUV (standardized uptake value), the metabolically active tumor "PET volume" was calculated. "PET metabolic volume" was obtained by multiplying the "PET volume" by the mean SUV of the tumor. All recurrent or metastatic lesions were single or multiple lesions of measurable size (axial diameter > 1 cm, minimum "PET volume" 3.5 cm3), and were verified by operation or by other imaging modalities (CT or MRI). There was a linear associations between "PET volume" and serum CEA level. Further regression analysis by least squares showed a highly significant model with an equation of volume = 41.2 + 0.471 x CEA (r2 = 0.629). However, no such association was found between "PET metabolic volume" and serum CEA level according to the residual normality test. In conclusion, "PET volume" measured by FDG PET and serum CEA level in colorectal cancer are significantly correlated. Tumor volume determined by FDG PET can be used as an effective marker of tumor burden in postoperative patients with colorectal carcinoma. |
| doi_str_mv | 10.1007/BF03027391 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_904471696</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1939662871</sourcerecordid><originalsourceid>FETCH-LOGICAL-c456t-35ec0fda251a94dd3df218fa20225cdb9a8c8da9788e8d45c79aff900fb71bfd3</originalsourceid><addsrcrecordid>eNqF0t9qFDEUBvAgil2rNz6ABAsKwmj-TpLLuu5WoaAX9XrIJGdwSiYZk8yWvoMP7ZQuFAT16nDgx3c48CH0kpL3lBD14eOecMIUN_QR2lDdiqYVnD9GG2KoaBTV6gQ9K-WaEKalZk_RCZWGGGHYBv3appwh2DqmiHuoNwARF8jLhLe7cxzgAAHb6PEE1fYpjA4fUlgmwLZgDxXyNEbwuL_F-08X-NvuCo8Rz6nUNENeYw-A53VArAXfjPUHzuCW9WSs2KWQ1q3agJ2NDvJz9GSwocCL4zxF3_e7q-3n5vLrxZft-WXjhGxrwyU4MnjLJLVGeM_9wKgeLCOMSed7Y7XT3hqlNWgvpFPGDoMhZOgV7QfPT9Hb-9w5p58LlNpNY3EQgo2QltIZIoSirWlX-eafslVa0laJ_0JGKRdS8RWe_QGv05Lj-m7HlFZMUKHMql7_VVFJhObs7ua7e-RyKiXD0M15nGy-7Sjp7prRPTRjxa-OiUs_gX-gxyrw33DUs6w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>215048324</pqid></control><display><type>article</type><title>Correlation between serum CEA level and metabolic volume as determined by FDG PET in postoperative patients with recurrent colorectal cancer</title><source>MEDLINE</source><source>SpringerLink Journals</source><source>Alma/SFX Local Collection</source><creator>Choi, Mi Yeon ; Lee, Kwang Min ; Chung, June-Key ; Lee, Dong Soo ; Jeong, Jae Min ; Park, Jae Gahb ; Kim, Jung-Hoe ; Lee, Myung Chul</creator><creatorcontrib>Choi, Mi Yeon ; Lee, Kwang Min ; Chung, June-Key ; Lee, Dong Soo ; Jeong, Jae Min ; Park, Jae Gahb ; Kim, Jung-Hoe ; Lee, Myung Chul</creatorcontrib><description>To determine the correlation between serum CEA level and the metabolic volume by FDG PET in postoperative patients with recurrent colorectal cancer, FDG PET was performed in 29 consecutive patients with recurrent or metastatic colorectal cancer whose CEA levels were higher than 5 ng/ml. A whole body emission scan was performed 60 minutes after injecting 370-555 MBq of F-18 FDG. "PET volume" and "PET metabolic volume" of tumors were measured on FDG PET images. Based on an isocontour plot of tumor mass at 2.5 SUV (standardized uptake value), the metabolically active tumor "PET volume" was calculated. "PET metabolic volume" was obtained by multiplying the "PET volume" by the mean SUV of the tumor. All recurrent or metastatic lesions were single or multiple lesions of measurable size (axial diameter > 1 cm, minimum "PET volume" 3.5 cm3), and were verified by operation or by other imaging modalities (CT or MRI). There was a linear associations between "PET volume" and serum CEA level. Further regression analysis by least squares showed a highly significant model with an equation of volume = 41.2 + 0.471 x CEA (r2 = 0.629). However, no such association was found between "PET metabolic volume" and serum CEA level according to the residual normality test. In conclusion, "PET volume" measured by FDG PET and serum CEA level in colorectal cancer are significantly correlated. Tumor volume determined by FDG PET can be used as an effective marker of tumor burden in postoperative patients with colorectal carcinoma.</description><identifier>ISSN: 0914-7187</identifier><identifier>EISSN: 1864-6433</identifier><identifier>DOI: 10.1007/BF03027391</identifier><identifier>PMID: 15909492</identifier><language>eng</language><publisher>Japan: Springer Nature B.V</publisher><subject>Biomarkers, Tumor - blood ; Cancer ; Carcinoembryonic Antigen - blood ; Colorectal cancer ; Colorectal carcinoma ; Colorectal Neoplasms - diagnostic imaging ; Colorectal Neoplasms - metabolism ; Colorectal Neoplasms - pathology ; Colorectal Neoplasms - secondary ; Computed tomography ; Correlation ; Diameters ; Fluorine isotopes ; Fluorodeoxyglucose F18 - pharmacokinetics ; Humans ; Image Interpretation, Computer-Assisted - methods ; Lesions ; Metabolism ; Metastases ; Metastasis ; Neoplasm Recurrence, Local - diagnostic imaging ; Neoplasm Recurrence, Local - metabolism ; Neoplasm Recurrence, Local - pathology ; Neoplasm Staging - methods ; Positron emission ; Positron emission tomography ; Positron-Emission Tomography - methods ; Radioisotopes ; Radiopharmaceuticals - pharmacokinetics ; Regression analysis ; Reproducibility of Results ; Retrospective Studies ; Sensitivity and Specificity ; Severity of Illness Index ; Statistics as Topic ; Tissue Distribution ; Tumors</subject><ispartof>Annals of nuclear medicine, 2005-04, Vol.19 (2), p.123-129</ispartof><rights>Springer 2005</rights><rights>Springer 2005.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c456t-35ec0fda251a94dd3df218fa20225cdb9a8c8da9788e8d45c79aff900fb71bfd3</citedby><cites>FETCH-LOGICAL-c456t-35ec0fda251a94dd3df218fa20225cdb9a8c8da9788e8d45c79aff900fb71bfd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15909492$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Choi, Mi Yeon</creatorcontrib><creatorcontrib>Lee, Kwang Min</creatorcontrib><creatorcontrib>Chung, June-Key</creatorcontrib><creatorcontrib>Lee, Dong Soo</creatorcontrib><creatorcontrib>Jeong, Jae Min</creatorcontrib><creatorcontrib>Park, Jae Gahb</creatorcontrib><creatorcontrib>Kim, Jung-Hoe</creatorcontrib><creatorcontrib>Lee, Myung Chul</creatorcontrib><title>Correlation between serum CEA level and metabolic volume as determined by FDG PET in postoperative patients with recurrent colorectal cancer</title><title>Annals of nuclear medicine</title><addtitle>Ann Nucl Med</addtitle><description>To determine the correlation between serum CEA level and the metabolic volume by FDG PET in postoperative patients with recurrent colorectal cancer, FDG PET was performed in 29 consecutive patients with recurrent or metastatic colorectal cancer whose CEA levels were higher than 5 ng/ml. A whole body emission scan was performed 60 minutes after injecting 370-555 MBq of F-18 FDG. "PET volume" and "PET metabolic volume" of tumors were measured on FDG PET images. Based on an isocontour plot of tumor mass at 2.5 SUV (standardized uptake value), the metabolically active tumor "PET volume" was calculated. "PET metabolic volume" was obtained by multiplying the "PET volume" by the mean SUV of the tumor. All recurrent or metastatic lesions were single or multiple lesions of measurable size (axial diameter > 1 cm, minimum "PET volume" 3.5 cm3), and were verified by operation or by other imaging modalities (CT or MRI). There was a linear associations between "PET volume" and serum CEA level. Further regression analysis by least squares showed a highly significant model with an equation of volume = 41.2 + 0.471 x CEA (r2 = 0.629). However, no such association was found between "PET metabolic volume" and serum CEA level according to the residual normality test. In conclusion, "PET volume" measured by FDG PET and serum CEA level in colorectal cancer are significantly correlated. Tumor volume determined by FDG PET can be used as an effective marker of tumor burden in postoperative patients with colorectal carcinoma.</description><subject>Biomarkers, Tumor - blood</subject><subject>Cancer</subject><subject>Carcinoembryonic Antigen - blood</subject><subject>Colorectal cancer</subject><subject>Colorectal carcinoma</subject><subject>Colorectal Neoplasms - diagnostic imaging</subject><subject>Colorectal Neoplasms - metabolism</subject><subject>Colorectal Neoplasms - pathology</subject><subject>Colorectal Neoplasms - secondary</subject><subject>Computed tomography</subject><subject>Correlation</subject><subject>Diameters</subject><subject>Fluorine isotopes</subject><subject>Fluorodeoxyglucose F18 - pharmacokinetics</subject><subject>Humans</subject><subject>Image Interpretation, Computer-Assisted - methods</subject><subject>Lesions</subject><subject>Metabolism</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Neoplasm Recurrence, Local - diagnostic imaging</subject><subject>Neoplasm Recurrence, Local - metabolism</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Staging - methods</subject><subject>Positron emission</subject><subject>Positron emission tomography</subject><subject>Positron-Emission Tomography - methods</subject><subject>Radioisotopes</subject><subject>Radiopharmaceuticals - pharmacokinetics</subject><subject>Regression analysis</subject><subject>Reproducibility of Results</subject><subject>Retrospective Studies</subject><subject>Sensitivity and Specificity</subject><subject>Severity of Illness Index</subject><subject>Statistics as Topic</subject><subject>Tissue Distribution</subject><subject>Tumors</subject><issn>0914-7187</issn><issn>1864-6433</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqF0t9qFDEUBvAgil2rNz6ABAsKwmj-TpLLuu5WoaAX9XrIJGdwSiYZk8yWvoMP7ZQuFAT16nDgx3c48CH0kpL3lBD14eOecMIUN_QR2lDdiqYVnD9GG2KoaBTV6gQ9K-WaEKalZk_RCZWGGGHYBv3appwh2DqmiHuoNwARF8jLhLe7cxzgAAHb6PEE1fYpjA4fUlgmwLZgDxXyNEbwuL_F-08X-NvuCo8Rz6nUNENeYw-A53VArAXfjPUHzuCW9WSs2KWQ1q3agJ2NDvJz9GSwocCL4zxF3_e7q-3n5vLrxZft-WXjhGxrwyU4MnjLJLVGeM_9wKgeLCOMSed7Y7XT3hqlNWgvpFPGDoMhZOgV7QfPT9Hb-9w5p58LlNpNY3EQgo2QltIZIoSirWlX-eafslVa0laJ_0JGKRdS8RWe_QGv05Lj-m7HlFZMUKHMql7_VVFJhObs7ua7e-RyKiXD0M15nGy-7Sjp7prRPTRjxa-OiUs_gX-gxyrw33DUs6w</recordid><startdate>20050401</startdate><enddate>20050401</enddate><creator>Choi, Mi Yeon</creator><creator>Lee, Kwang Min</creator><creator>Chung, June-Key</creator><creator>Lee, Dong Soo</creator><creator>Jeong, Jae Min</creator><creator>Park, Jae Gahb</creator><creator>Kim, Jung-Hoe</creator><creator>Lee, Myung Chul</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20050401</creationdate><title>Correlation between serum CEA level and metabolic volume as determined by FDG PET in postoperative patients with recurrent colorectal cancer</title><author>Choi, Mi Yeon ; Lee, Kwang Min ; Chung, June-Key ; Lee, Dong Soo ; Jeong, Jae Min ; Park, Jae Gahb ; Kim, Jung-Hoe ; Lee, Myung Chul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c456t-35ec0fda251a94dd3df218fa20225cdb9a8c8da9788e8d45c79aff900fb71bfd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Biomarkers, Tumor - blood</topic><topic>Cancer</topic><topic>Carcinoembryonic Antigen - blood</topic><topic>Colorectal cancer</topic><topic>Colorectal carcinoma</topic><topic>Colorectal Neoplasms - diagnostic imaging</topic><topic>Colorectal Neoplasms - metabolism</topic><topic>Colorectal Neoplasms - pathology</topic><topic>Colorectal Neoplasms - secondary</topic><topic>Computed tomography</topic><topic>Correlation</topic><topic>Diameters</topic><topic>Fluorine isotopes</topic><topic>Fluorodeoxyglucose F18 - pharmacokinetics</topic><topic>Humans</topic><topic>Image Interpretation, Computer-Assisted - methods</topic><topic>Lesions</topic><topic>Metabolism</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Neoplasm Recurrence, Local - diagnostic imaging</topic><topic>Neoplasm Recurrence, Local - metabolism</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Staging - methods</topic><topic>Positron emission</topic><topic>Positron emission tomography</topic><topic>Positron-Emission Tomography - methods</topic><topic>Radioisotopes</topic><topic>Radiopharmaceuticals - pharmacokinetics</topic><topic>Regression analysis</topic><topic>Reproducibility of Results</topic><topic>Retrospective Studies</topic><topic>Sensitivity and Specificity</topic><topic>Severity of Illness Index</topic><topic>Statistics as Topic</topic><topic>Tissue Distribution</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Choi, Mi Yeon</creatorcontrib><creatorcontrib>Lee, Kwang Min</creatorcontrib><creatorcontrib>Chung, June-Key</creatorcontrib><creatorcontrib>Lee, Dong Soo</creatorcontrib><creatorcontrib>Jeong, Jae Min</creatorcontrib><creatorcontrib>Park, Jae Gahb</creatorcontrib><creatorcontrib>Kim, Jung-Hoe</creatorcontrib><creatorcontrib>Lee, Myung Chul</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of nuclear medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Choi, Mi Yeon</au><au>Lee, Kwang Min</au><au>Chung, June-Key</au><au>Lee, Dong Soo</au><au>Jeong, Jae Min</au><au>Park, Jae Gahb</au><au>Kim, Jung-Hoe</au><au>Lee, Myung Chul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correlation between serum CEA level and metabolic volume as determined by FDG PET in postoperative patients with recurrent colorectal cancer</atitle><jtitle>Annals of nuclear medicine</jtitle><addtitle>Ann Nucl Med</addtitle><date>2005-04-01</date><risdate>2005</risdate><volume>19</volume><issue>2</issue><spage>123</spage><epage>129</epage><pages>123-129</pages><issn>0914-7187</issn><eissn>1864-6433</eissn><abstract>To determine the correlation between serum CEA level and the metabolic volume by FDG PET in postoperative patients with recurrent colorectal cancer, FDG PET was performed in 29 consecutive patients with recurrent or metastatic colorectal cancer whose CEA levels were higher than 5 ng/ml. A whole body emission scan was performed 60 minutes after injecting 370-555 MBq of F-18 FDG. "PET volume" and "PET metabolic volume" of tumors were measured on FDG PET images. Based on an isocontour plot of tumor mass at 2.5 SUV (standardized uptake value), the metabolically active tumor "PET volume" was calculated. "PET metabolic volume" was obtained by multiplying the "PET volume" by the mean SUV of the tumor. All recurrent or metastatic lesions were single or multiple lesions of measurable size (axial diameter > 1 cm, minimum "PET volume" 3.5 cm3), and were verified by operation or by other imaging modalities (CT or MRI). There was a linear associations between "PET volume" and serum CEA level. Further regression analysis by least squares showed a highly significant model with an equation of volume = 41.2 + 0.471 x CEA (r2 = 0.629). However, no such association was found between "PET metabolic volume" and serum CEA level according to the residual normality test. In conclusion, "PET volume" measured by FDG PET and serum CEA level in colorectal cancer are significantly correlated. Tumor volume determined by FDG PET can be used as an effective marker of tumor burden in postoperative patients with colorectal carcinoma.</abstract><cop>Japan</cop><pub>Springer Nature B.V</pub><pmid>15909492</pmid><doi>10.1007/BF03027391</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0914-7187 |
| ispartof | Annals of nuclear medicine, 2005-04, Vol.19 (2), p.123-129 |
| issn | 0914-7187 1864-6433 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_904471696 |
| source | MEDLINE; SpringerLink Journals; Alma/SFX Local Collection |
| subjects | Biomarkers, Tumor - blood Cancer Carcinoembryonic Antigen - blood Colorectal cancer Colorectal carcinoma Colorectal Neoplasms - diagnostic imaging Colorectal Neoplasms - metabolism Colorectal Neoplasms - pathology Colorectal Neoplasms - secondary Computed tomography Correlation Diameters Fluorine isotopes Fluorodeoxyglucose F18 - pharmacokinetics Humans Image Interpretation, Computer-Assisted - methods Lesions Metabolism Metastases Metastasis Neoplasm Recurrence, Local - diagnostic imaging Neoplasm Recurrence, Local - metabolism Neoplasm Recurrence, Local - pathology Neoplasm Staging - methods Positron emission Positron emission tomography Positron-Emission Tomography - methods Radioisotopes Radiopharmaceuticals - pharmacokinetics Regression analysis Reproducibility of Results Retrospective Studies Sensitivity and Specificity Severity of Illness Index Statistics as Topic Tissue Distribution Tumors |
| title | Correlation between serum CEA level and metabolic volume as determined by FDG PET in postoperative patients with recurrent colorectal cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T14%3A33%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correlation%20between%20serum%20CEA%20level%20and%20metabolic%20volume%20as%20determined%20by%20FDG%20PET%20in%20postoperative%20patients%20with%20recurrent%20colorectal%20cancer&rft.jtitle=Annals%20of%20nuclear%20medicine&rft.au=Choi,%20Mi%20Yeon&rft.date=2005-04-01&rft.volume=19&rft.issue=2&rft.spage=123&rft.epage=129&rft.pages=123-129&rft.issn=0914-7187&rft.eissn=1864-6433&rft_id=info:doi/10.1007/BF03027391&rft_dat=%3Cproquest_cross%3E1939662871%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=215048324&rft_id=info:pmid/15909492&rfr_iscdi=true |